{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:53:56Z","timestamp":1773471236835,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation of Hubei Science & Technology Department","award":["2018ACA162\uff0c2021DFE026"],"award-info":[{"award-number":["2018ACA162\uff0c2021DFE026"]}]},{"name":"Hubei Province\u2019s Outstanding Medical Academic Leader program, the Foundation of Hubei University of Medicine","award":["HBMUPI201807"],"award-info":[{"award-number":["HBMUPI201807"]}]},{"name":"Hubei Province\u2019s Outstanding Medical Academic Leader program, the Foundation of Hubei University of Medicine","award":["FDFR201601"],"award-info":[{"award-number":["FDFR201601"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670272"],"award-info":[{"award-number":["81670272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270299"],"award-info":[{"award-number":["82270299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB624"],"award-info":[{"award-number":["2020CFB624"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB355"],"award-info":[{"award-number":["2020CFB355"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019076","name":"Outstanding Young and Middle-aged Scientific Innovation Team of Colleges and Universities of Hubei Province","doi-asserted-by":"publisher","award":["Q2021104"],"award-info":[{"award-number":["Q2021104"]}],"id":[{"id":"10.13039\/501100019076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Foundation of Hubei University of Medicine","award":["2019QDJZR09"],"award-info":[{"award-number":["2019QDJZR09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinically, Charcot-Marie-Tooth disease (CMT)-associated muscle atrophy still lacks effective treatment. Deletion and mutation of L-periaxin can be involved in CMT type 4F (CMT4F) by destroying the myelin sheath form, which may be related to the inhibitory role of Ezrin in the self-association of L-periaxin. However, it is still unknown whether L-periaxin and Ezrin are independently or interactively involved in the process of muscle atrophy by affecting the function of muscle satellite cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A gastrocnemius muscle atrophy model was prepared to mimic CMT4F and its associated muscle atrophy by mechanical clamping of the peroneal nerve. Differentiating C2C12 myoblast cells were treated with adenovirus-mediated overexpression or knockdown of Ezrin. Then, overexpression of L-periaxin and NFATc1\/c2 or knockdown of L-periaxin and NFATc3\/c4 mediated by adenovirus\u00a0vectors were used to confirm their role in Ezrin-mediated myoblast differentiation, myotube formation and gastrocnemius muscle repair in a peroneal nerve injury model. RNA-seq, real-time PCR, immunofluorescence staining and Western blot were used in the above observation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For the first time, instantaneous L-periaxin expression was highest on the 6th day, while Ezrin expression peaked on the 4th day during myoblast differentiation\/fusion in vitro. In vivo transduction of adenovirus\u00a0vectors carrying Ezrin, but not Periaxin, into the gastrocnemius muscle in a peroneal nerve injury model increased the numbers of muscle myosin heavy chain (MyHC) I and II type myofibers, reducing muscle atrophy and fibrosis. Local muscle injection of overexpressed Ezrin combined with incubation of knockdown L-periaxin within the injured peroneal nerve or injection of knockdown L-periaxin into peroneal nerve-injured gastrocnemius muscle not only increased the number of muscle fibers but also recovered their size to a relatively normal level in vivo\n                      <jats:italic>.<\/jats:italic>\n                      Overexpression of Ezrin promoted myoblast differentiation\/fusion, inducing increased MyHC-I\n                      <jats:sup>+<\/jats:sup>\n                      and MyHC-II\u2009+\u2009muscle fiber specialization, and the specific effects could be enhanced by the addition of adenovirus\u00a0vectors for knockdown of L-periaxin by shRNA. Overexpression of L-periaxin did not alter the inhibitory effects on myoblast differentiation and fusion mediated by knockdown of Ezrin by shRNA in vitro but decreased myotube length and size. Mechanistically, overexpressing Ezrin did not alter protein kinase A gamma catalytic subunit (PKA-\u03b3 cat), protein kinase A I alpha regulatory subunit (PKA reg I\u03b1) or PKA reg I\u03b2 levels but increased PKA-\u03b1 cat and PKA reg II \u03b1 levels, leading to a decreased ratio of PKA reg I\/II. The PKA inhibitor H-89 remarkably abolished the effects of overexpressing-Ezrin on increased myoblast differentiation\/fusion. In contrast, knockdown of Ezrin by shRNA significantly delayed myoblast differentiation\/fusion accompanied by an increased PKA reg I\/II ratio, and the inhibitory effects could be eliminated by the PKA reg activator N6-Bz-cAMP. Meanwhile, overexpressing Ezrin enhanced type I muscle fiber specialization, accompanied by an increase in NFATc2\/c3 levels and a decrease in NFATc1 levels. Furthermore, overexpressing NFATc2 or knocking down NFATc3 reversed the inhibitory effects of Ezrin knockdown on myoblast differentiation\/fusion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The spatiotemporal pattern of Ezrin\/Periaxin expression was involved in the control of myoblast differentiation\/fusion, myotube length and size, and myofiber specialization, which was related to the activated PKA-NFAT-MEF2C signaling pathway, providing a novel L-Periaxin\/Ezrin joint strategy for the treatment of muscle atrophy induced by nerve injury, especially in CMT4F.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04016-7","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T05:02:50Z","timestamp":1677906170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The spatiotemporal matching pattern of Ezrin\/Periaxin involved in myoblast differentiation and fusion and Charcot-Marie-Tooth disease-associated muscle atrophy"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruo-nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdaleena Naemi","family":"Mbadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-tao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-you","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-liu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-7626","authenticated-orcid":false,"given":"Jun-ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"issue":"4","key":"4016_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/hmg\/10.4.415","volume":"10","author":"A Guilbot","year":"2001","unstructured":"Guilbot A, Williams A, Ravis\u00e9 N, Verny C, Brice A, Sherman DL, et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet. 2001;10(4):415\u201321.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4016_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13287-018-0993-z","volume":"9","author":"K Kowalski","year":"2018","unstructured":"Kowalski K, Dos Santos M, Maire P, Ciemerych MA, Brzoska E. Induction of bone marrow-derived cells myogenic identity by their interactions with the satellite cell niche. Stem Cell Res Ther. 2018;9(1):258.","journal-title":"Stem Cell Res Ther"},{"key":"4016_CR3","doi-asserted-by":"publisher","first-page":"113086","DOI":"10.1016\/j.expneurol.2019.113086","volume":"323","author":"C Sun","year":"2020","unstructured":"Sun C, Serra C, Lee G, Wagner KR. Stem cell-based therapies for Duchenne muscular dystrophy. Exp Neurol. 2020;323:113086.","journal-title":"Exp Neurol"},{"issue":"4","key":"4016_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1469-7580.2002.00038.x","volume":"200","author":"AC Williams","year":"2002","unstructured":"Williams AC, Brophy PJ. The function of the Periaxin gene during nerve repair in a model of CMT4F. J Anatomy. 2002;200(4):323\u201330.","journal-title":"J Anatomy"},{"issue":"4","key":"4016_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129520","volume":"1864","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang L, Xiao H, Yang Y, Shi YW. Ezrin interacts with L-periaxin by the \u201chead to head and tail to tail\u201d mode and influences the location of L-periaxin in Schwann cell RSC96. BBA - General Subj. 2020;1864(4): 129520.","journal-title":"BBA - General Subj"},{"issue":"1","key":"4016_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/CritRevImmunol.2015012327","volume":"35","author":"D Pore","year":"2015","unstructured":"Pore D, Gupta N. Ezrin-radixin-moesin family proteins in the regulation of B-cell immune response. Crit Rev Immunol. 2015;35(1):15\u201331.","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"4016_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev. 2013;93(1):23\u201367.","journal-title":"Physiol Rev"},{"issue":"1","key":"4016_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1016-8478(23)15075-8","volume":"14","author":"SY Han","year":"2002","unstructured":"Han SY, Park DY, Lee GH, Park SD, Hong SH. Involvement of type I protein kinase An in the differentiation of L6 myoblast in conjunction with phosphatidylinositol 3-kinase. Mol Cells. 2002;14(1):68\u201374.","journal-title":"Mol Cells"},{"issue":"1","key":"4016_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13287-019-1160-x","volume":"10","author":"SJ Chen","year":"2019","unstructured":"Chen SJ, Yue J, Zhang JX, Jiang M, Hu TQ, Leng WD, et al. Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA\/ERK1\/2-FOXO1 signaling pathway. Stem Cell Res Ther. 2019;10(1):70.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4016_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1248\/bpb.b16-01011","volume":"40","author":"K Kawaguchi","year":"2017","unstructured":"Kawaguchi K, Yoshida S, Hatano R, Asano S. Pathophysiological Roles of Ezrin\/Radixin\/Moesin Proteins. Biol Pharm Bull. 2017;40(4):381\u201390.","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nrm882","volume":"3","author":"A Bretscher","year":"2002","unstructured":"Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol. 2002;3(8):586\u201399.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4016_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2020.08.039","volume":"183","author":"A Reddy","year":"2020","unstructured":"Reddy A, Bozi LHM, Yaghi OK, Mills EL, Xiao H, Nicholson HE, et al. pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise. Cell. 2020;183(1):62-75.e17.","journal-title":"Cell"},{"issue":"2","key":"4016_CR13","doi-asserted-by":"publisher","first-page":"G185","DOI":"10.1152\/ajpgi.90597.2008","volume":"296","author":"L Zhu","year":"2009","unstructured":"Zhu L, Hatakeyama J, Zhang B, Makdisi J, Ender C, Forte JG. Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G185\u201395.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"4016_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41598-022-22330-w","volume":"13","author":"J Yue","year":"2023","unstructured":"Yue J, Xu W, Xiang L, Chen SJ, Li XY, Yang Q, et al. Continuous exposure to isoprenaline reduced myotube size by delaying myoblast differentiation and fusion through the NFAT-MEF2C signaling pathway. Sci Rep. 2023;13(1):436.","journal-title":"Sci Rep"},{"issue":"8","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"C671","DOI":"10.1152\/ajpcell.00335.2013","volume":"307","author":"MR Hicks","year":"2014","unstructured":"Hicks MR, Cao TV, Standley PR. Biomechanical strain vehicles for fibroblast-directed skeletal myoblast differentiation and myotube functionality in a novel coculture. Am J Physiol Cell Physiol. 2014;307(8):C671\u201383.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"4016_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0092-8674(03)00319-2","volume":"113","author":"V Horsley","year":"2003","unstructured":"Horsley V, Jansen KM, Mills ST, Pavlath GK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell. 2003;113(4):483\u201394.","journal-title":"Cell"},{"issue":"36","key":"4016_CR17","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1093\/eurheartj\/ehab503","volume":"42","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Ling S, Li J, Zhong G, Du R, Li Y, et al. 3\u2019 untranslated region of Ckip-1 inhibits cardiac hypertrophy independently of its cognate protein. Eur Heart J. 2021;42(36):3786\u201399.","journal-title":"Eur Heart J"},{"issue":"1","key":"4016_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13287-018-0770-z","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Wan J, Yu B, Diao Y, Zhang W. PIP5K1\u03b1 promotes myogenic differentiation via AKT activation and calcium release. Stem Cell Res Ther. 2018;9(1):33.","journal-title":"Stem Cell Res Ther"},{"key":"4016_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12967-016-0847-3","volume":"14","author":"GH Li","year":"2016","unstructured":"Li GH, Luo B, Lv YX, Zheng F, Wang L, Wei MX, et al. Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury. J Transl Med. 2016;14:116.","journal-title":"J Transl Med"},{"key":"4016_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.biopha.2018.02.096","volume":"101","author":"X Cheng","year":"2018","unstructured":"Cheng X, Du J, Shen L, Tan Z, Jiang D, Jiang A, et al. MiR-204-5p regulates C2C12 myoblast differentiation by targeting MEF2C and ERR\u03b3. Biomed Pharmacother. 2018;101:528\u201335.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"4016_CR21","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.1074\/jbc.M611322200","volume":"282","author":"YY Cho","year":"2007","unstructured":"Cho YY, Yao K, Bode AM, Bergen HR 3rd, Madden BJ, Oh SM, et al. RSK2 mediates muscle cell differentiation through regulation of NFAT3. J Biol Chem. 2007;282(11):8380\u201392.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"4016_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1242\/jcs.03307","volume":"120","author":"RS O'Connor","year":"2007","unstructured":"O\u2019Connor RS, Mills ST, Jones KA, Ho SN, Pavlath GK. A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J Cell Sci. 2007;120(Pt 1):149\u201359.","journal-title":"J Cell Sci"},{"issue":"1","key":"4016_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/dbio.2001.0179","volume":"232","author":"KM Kegley","year":"2001","unstructured":"Kegley KM, Gephart J, Warren GL, Pavlath GK. Altered primary myogenesis in NFATC3(-\/-) mice leads to decreased muscle size in the adult. Dev Biol. 2001;232(1):115\u201326.","journal-title":"Dev Biol"},{"key":"4016_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.lfs.2018.11.020","volume":"215","author":"M Xu","year":"2018","unstructured":"Xu M, Chen X, Chen D, Yu B, Li M, He J, et al. MicroRNA-499\u20135p regulates skeletal myotube specification via NFATc1\/MEF2C pathway and Thrap1\/MEF2C axis. Life Sci. 2018;215:236\u201345.","journal-title":"Life Sci"},{"issue":"32","key":"4016_CR25","doi-asserted-by":"publisher","first-page":"13335","DOI":"10.1073\/pnas.0812911106","volume":"106","author":"E Calabria","year":"2009","unstructured":"Calabria E, Ciciliot S, Moretti I, Garcia M, Picard A, Dyar KA, et al. NFAT isoforms control activity-dependent muscle fiber type specification. Proc Natl AcadSci U S A. 2009;106(32):13335\u201340.","journal-title":"Proc Natl AcadSci U S A"},{"issue":"7","key":"4016_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00109-018-1657-2","volume":"96","author":"J Du","year":"2018","unstructured":"Du J, Shen L, Zhang P, Tan Z, Cheng X, Luo J, et al. The regulation of skeletal muscle fiber-type composition by betaine is associated with NFATc1\/MyoD. J Mol Med (Berl). 2018;96(7):685\u2013700.","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"4016_CR27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.celrep.2014.08.035","volume":"8","author":"ML Ehlers","year":"2014","unstructured":"Ehlers ML, Celona B, Black BL. NFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoDactivity. Cell Rep. 2014;8(6):1639\u201348.","journal-title":"Cell Rep"},{"issue":"5","key":"4016_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1083\/jcb.153.5.985","volume":"153","author":"S Palmer","year":"2001","unstructured":"Palmer S, Groves N, Schindeler A, Yeoh T, Biben C, Wang CC, et al. The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner. J Cell Biol. 2001;153(5):985\u201398.","journal-title":"J Cell Biol"},{"issue":"5","key":"4016_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1139\/bcb-2018-0208","volume":"97","author":"SK Doddi","year":"2019","unstructured":"Doddi SK, Kummari G, Jagannadham MV, Kalle AM. Protein kinase A mediates novel serine-584 phosphorylation of HDAC4. Biochem Cell Biol. 2019;97(5):526\u201335.","journal-title":"Biochem Cell Biol"},{"key":"4016_CR30","first-page":"37","volume":"46","author":"HH Arnold","year":"1992","unstructured":"Arnold HH, Braun T, Bober E, Buchberger A, Winter B, Salminen A. Regulation of myogenin expression in normal and transformed myogenic cell lines. SympSocExp Biol. 1992;46:37\u201351.","journal-title":"SympSocExp Biol"},{"key":"4016_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gep.2019.119079","volume":"35","author":"Y Lin","year":"2020","unstructured":"Lin Y, Xie Z, Zhou J, Yin G, Lin H. Differential gene and protein expression in gastrocnemius and tibialis anterior muscle following tibial and peroneal nerve injury in rats. Gene Expr Patterns. 2020;35: 119079.","journal-title":"Gene Expr Patterns"},{"issue":"10","key":"4016_CR32","first-page":"5943","volume":"13","author":"S Hardy","year":"1993","unstructured":"Hardy S, Kong Y, Konieczny SF. Fibroblast growth factor inhibits MRF4activity independently of the phosphorylation status of a conserved threonineresidue within the DNA-binding domain. Mol Cell Biol. 1993;13(10):5943\u201356.","journal-title":"Mol Cell Biol"},{"issue":"13","key":"4016_CR33","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1016\/S0021-9258(18)98426-7","volume":"268","author":"B Winter","year":"1993","unstructured":"Winter B, Braun T, Arnold HH. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J Biol Chem. 1993;268(13):9869\u201378.","journal-title":"J Biol Chem"},{"issue":"1","key":"4016_CR34","first-page":"41","volume":"37","author":"A Khalilimeybodi","year":"2018","unstructured":"Khalilimeybodi A, Daneshmehr A, Sharif KB. Ca2+-dependent calcineurin\/NFAT signaling in \u03b2-adrenergic-induced cardiac hypertrophy. GenPhysiolBiophys. 2018;37(1):41\u201356.","journal-title":"GenPhysiolBiophys"},{"issue":"5","key":"4016_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1083\/jcb.200111073","volume":"156","author":"V Horsley","year":"2002","unstructured":"Horsley V, PavlathGK. NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol. 2002;156(5):771\u20134.","journal-title":"J Cell Biol"},{"issue":"4","key":"4016_CR36","doi-asserted-by":"publisher","first-page":"C915","DOI":"10.1152\/ajpcell.2000.279.4.C915","volume":"279","author":"SJ Swoap","year":"2000","unstructured":"Swoap SJ, Hunter RB, Stevenson EJ, Felton HM, Kansagra NV, Lang JM, et al. Thecalcineurin-NFAT pathway and muscle fiber-type gene expression. Am J Physiol Cell Physiol. 2000;279(4):C915\u201324.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"24","key":"4016_CR37","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1242\/dev.097428","volume":"140","author":"N Daou","year":"2013","unstructured":"Daou N, Lecolle S, Lefebvre S, dellaGaspera B, Charbonnier F, Chanoine C, et al. A new role for the calcineurin\/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2\/MyoD complex during mouse myogenesis. Development. 2013;140(24):4914\u201325.","journal-title":"Development"},{"issue":"2","key":"4016_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1083\/jcb.153.2.329","volume":"153","author":"V Horsley","year":"2001","unstructured":"Horsley V, Friday BB, Matteson S, Kegley KM, Gephart J, PavlathGK. Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J Cell Biol. 2001;153(2):329\u201338.","journal-title":"J Cell Biol"},{"issue":"18","key":"4016_CR39","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1242\/jcs.198978","volume":"130","author":"J Perroud","year":"2017","unstructured":"Perroud J, Bernheim L, Frieden M, Koenig S. Distinct roles of NFATc1 and NFATc4 in human primary myoblast differentiation and in the maintenance of reserve cells. J Cell Sci. 2017;130(18):3083\u201393.","journal-title":"J Cell Sci"},{"issue":"10","key":"4016_CR40","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1172\/JCI92067","volume":"127","author":"JH Koo","year":"2017","unstructured":"Koo JH, Kim TH, Park SY, Joo MS, Han CY, Choi CS, et al. G\u03b113 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism. J Clin Invest. 2017;127(10):3845\u201360.","journal-title":"J Clin Invest"},{"issue":"29","key":"4016_CR41","doi-asserted-by":"publisher","first-page":"10590","DOI":"10.1073\/pnas.0308035101","volume":"101","author":"KJ McCullagh","year":"2004","unstructured":"McCullagh KJ, Calabria E, Pallafacchina G, Ciciliot S, Serrano AL, Argentini C, et al. NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl AcadSci U S A. 2004;101(29):10590\u20135.","journal-title":"Proc Natl AcadSci U S A"},{"issue":"2","key":"4016_CR42","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbrc.2012.11.082","volume":"430","author":"TT Phuong","year":"2013","unstructured":"Phuong TT, Yun YH, Kim SJ, Kang TM. Positive feedback control between STIM1 and NFATc3 is required for C2C12 myoblast differentiation. Biochem Biophys Res Commun. 2013;430(2):722\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"4016_CR43","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1128\/MCB.20.17.6600-6611.2000","volume":"20","author":"U Delling","year":"2000","unstructured":"Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol. 2000;20(17):6600\u201311.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"4016_CR44","doi-asserted-by":"publisher","first-page":"C1887","DOI":"10.1152\/ajpcell.00506.2006","volume":"292","author":"CM Alfieri","year":"2007","unstructured":"Alfieri CM, Evans-Anderson HJ, Yutzey KE. Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle. Am J Physiol Cell Physiol. 2007;292(5):C1887\u201394.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"43","key":"4016_CR45","doi-asserted-by":"publisher","first-page":"29004","DOI":"10.1074\/jbc.M801297200","volume":"283","author":"AS Armand","year":"2008","unstructured":"Armand AS, Bourajjaj M, Mart\u00ednez-Mart\u00ednez S, el Azzouzi H, da Costa Martins PA, Hatzis P, et al. Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. J Biol Chem. 2008;283(43):29004\u201310.","journal-title":"J Biol Chem"},{"issue":"12","key":"4016_CR46","doi-asserted-by":"publisher","first-page":"10704","DOI":"10.1074\/jbc.M107068200","volume":"277","author":"B Zhou","year":"2002","unstructured":"Zhou B, Cron RQ, Wu B, Genin A, Wang Z, Liu S, et al. Regulation of the murine Nfatc1 gene by NFATc2. Biol Chem. 2002;277(12):10704\u201311.","journal-title":"Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04016-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04016-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04016-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:24:29Z","timestamp":1729005869000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04016-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04016-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2143901\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"173"}}